Literature DB >> 8980738

Migration of human glioma cells in response to tumour cyst fluids.

A Giese1, F Schröder, A Steiner, M Westphal.   

Abstract

Glial tumours often show high degrees of local invasion that lead to local recurrence of the disease. Extracellular matrix components as well as soluble factors may play a critical role in this poorly understood process. Cyst fluid from human brain tumours may accumulate such autocrine produced factors and may represent a source were those factors may be easily obtained and studied. We have studied the effect of cyst fluids harvested from 17 glial tumours, 3 meningiomas, and three metastases on the motility of established human glioma cell lines. Both cyst fluids of high grade and low grade gliomas contained varying degrees of motility enhancing activity. No such activity was identified in cyst fluids obtained from meningiomas. The relation of mitogenic and motogenic activity in three selected cyst fluids was analysed using a quantitative monolayer migration assay. Quantitative analysis of cyst fluid effects on both proliferation and migration indicate that tumour cyst fluids contain factors that strongly stimulate cell migration and that maximum stimulation of migration did not occur at concentrations optimal for cell proliferation. Our findings indicate that glial tumours in fact produce and secrete soluble factors that may contribute to their dissemination in brain tissue.

Entities:  

Mesh:

Year:  1996        PMID: 8980738     DOI: 10.1007/bf01411064

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  34 in total

1.  The incidence of interhemispheric extension of glioblastoma multiforme through the corpus callosum.

Authors:  H P MAXWELL
Journal:  J Neurosurg       Date:  1946-01       Impact factor: 5.115

2.  Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression.

Authors:  M E Berens; M D Rief; J R Shapiro; D Haskett; A Giese; A Joy; S W Coons
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

Review 3.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

4.  Immunohistochemical demonstration of serum proteins in human cerebral gliomas.

Authors:  R J Seitz; W Wechsler
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 5.  Supratentorial low-grade gliomas.

Authors:  B L Guthrie; E R Laws
Journal:  Neurosurg Clin N Am       Date:  1990-01       Impact factor: 2.509

6.  Assessment of brain tumor cell motility in vivo and in vitro.

Authors:  M R Chicoine; D L Silbergeld
Journal:  J Neurosurg       Date:  1995-04       Impact factor: 5.115

Review 7.  Optic nerve glioma presenting as a huge intrasellar mass. Case report.

Authors:  I H Tekkök; K Tahta; S Saglam
Journal:  J Neurosurg Sci       Date:  1994-06       Impact factor: 2.279

8.  Somatomedins in tumour cyst fluid, cerebrospinal fluid, and tumour cytosol in patients with glial tumours.

Authors:  P Prisell; L Persson; J Boethius; V Sara
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

9.  Thymidine kinase in brain-tumor cysts.

Authors:  L Persson; J Boethius; J S Gronowitz; C Källander; L Lindgren
Journal:  J Neurosurg       Date:  1985-10       Impact factor: 5.115

10.  Platelet-derived growth factor (PDGF) in neoplastic and non-neoplastic cystic lesions of the central nervous system and in the cerebrospinal fluid.

Authors:  M Nistér; P Enblad; G Bäckström; T Söderman; L Persson; C H Heldin; B Westermark
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

View more
  2 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Migratory activity of human glioma cell lines in vitro assessed by continuous single cell observation.

Authors:  T Demuth; N J Hopf; O Kempski; D Sauner; M Herr; A Giese; A Perneczky
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.